Tags

Type your tag names separated by a space and hit enter

Catheter ablation for the treatment of paroxysmal supraventricular tachycardia.
J Cardiovasc Electrophysiol. 1995 Oct; 6(10 Pt 2):951-61.JC

Abstract

Radiofrequency catheter ablation has evolved into a front-line curative therapy for patients who have paroxysmal supraventricular tachycardia secondary to Wolff-Parkinson-White syndrome. AV nodal reentrant tachycardia, and atrial tachycardia. In patients with accessory pathways, cure rates exceed 90% in almost all anatomic locations. Equally high success rates are noted in patients with atriofascicular pathways and the permanent form of junctional reciprocating tachycardia. Complications secondary to catheter ablation of accessory pathways occur in 1% to 3% of patients and include cardiac perforation, tamponade, AV block, and stroke. In patients with AV modal reentrant tachycardia, selective slow pathway ablation is curative in over 95% of patients with a very low risk of AV block. Atrial tachycardias originating in both the left and right atria can be successfully ablated in over 80% of patients. Given the overall effectiveness of this procedure, radiofrequency catheter ablation should be considered as front-line therapy in patients with recurrent or drug-refractory paroxysmal supraventricular tachycardia. Although an effective therapy, the risks and benefits of this procedure need to be assessed in all patients who are candidates for this procedure.

Authors+Show Affiliations

Electrophysiology Laboratory, University of Texas Medical School at Houston, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8548116

Citation

Naccarelli, G V., et al. "Catheter Ablation for the Treatment of Paroxysmal Supraventricular Tachycardia." Journal of Cardiovascular Electrophysiology, vol. 6, no. 10 Pt 2, 1995, pp. 951-61.
Naccarelli GV, Shih HT, Jalal S. Catheter ablation for the treatment of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol. 1995;6(10 Pt 2):951-61.
Naccarelli, G. V., Shih, H. T., & Jalal, S. (1995). Catheter ablation for the treatment of paroxysmal supraventricular tachycardia. Journal of Cardiovascular Electrophysiology, 6(10 Pt 2), 951-61.
Naccarelli GV, Shih HT, Jalal S. Catheter Ablation for the Treatment of Paroxysmal Supraventricular Tachycardia. J Cardiovasc Electrophysiol. 1995;6(10 Pt 2):951-61. PubMed PMID: 8548116.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Catheter ablation for the treatment of paroxysmal supraventricular tachycardia. AU - Naccarelli,G V, AU - Shih,H T, AU - Jalal,S, PY - 1995/10/1/pubmed PY - 1995/10/1/medline PY - 1995/10/1/entrez SP - 951 EP - 61 JF - Journal of cardiovascular electrophysiology JO - J. Cardiovasc. Electrophysiol. VL - 6 IS - 10 Pt 2 N2 - Radiofrequency catheter ablation has evolved into a front-line curative therapy for patients who have paroxysmal supraventricular tachycardia secondary to Wolff-Parkinson-White syndrome. AV nodal reentrant tachycardia, and atrial tachycardia. In patients with accessory pathways, cure rates exceed 90% in almost all anatomic locations. Equally high success rates are noted in patients with atriofascicular pathways and the permanent form of junctional reciprocating tachycardia. Complications secondary to catheter ablation of accessory pathways occur in 1% to 3% of patients and include cardiac perforation, tamponade, AV block, and stroke. In patients with AV modal reentrant tachycardia, selective slow pathway ablation is curative in over 95% of patients with a very low risk of AV block. Atrial tachycardias originating in both the left and right atria can be successfully ablated in over 80% of patients. Given the overall effectiveness of this procedure, radiofrequency catheter ablation should be considered as front-line therapy in patients with recurrent or drug-refractory paroxysmal supraventricular tachycardia. Although an effective therapy, the risks and benefits of this procedure need to be assessed in all patients who are candidates for this procedure. SN - 1045-3873 UR - https://www.unboundmedicine.com/medline/citation/8548116/Catheter_ablation_for_the_treatment_of_paroxysmal_supraventricular_tachycardia_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=1045-3873&date=1995&volume=6&issue=10 Pt 2&spage=951 DB - PRIME DP - Unbound Medicine ER -